ReviewCancers2019

Is the Blood an Alternative for Programmed Cell Death Ligand 1 Assessment in Non-Small Cell Lung Cancer?

Emmanuel Acheampong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.